FDA Clearance Tracker · P170013
Low-Profile Visualized Intraluminal Support (LVIS) and LVIS Jr.
Last checked: Nov 19, 2026Latest source record: May 30, 2018 (this decision)Source: openFDAMethods & limitations
Decided
May 30, 2018
Approved
Time to decision
425 days
Received Mar 31, 2017. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P170013
- Device name
- Low-Profile Visualized Intraluminal Support (LVIS) and LVIS Jr.
- Applicant
- MicroVention, Inc.
- Applicant location
- Aliso Viejo, CA
- Received
- Mar 31, 2017
- Decided
- May 30, 2018
- Decision
- Approved
- Supplements
- 12 in FDA's data for this PMA. See them on the FDA record
Device type
- Device type
- Intracranial coil-assist stent (QCA)
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval for the Low-Profile Visualized Intraluminal Support (LVIS) and LVIS Jr. This device is indicated for use with neurovascular embolization coils in patients >= 18 years of age for the treatment of wide-neck (neck width >= 4 mm or dome to neck ratio < 2) saccular intracranial aneurysms arising from a parent vessel with a diameter >= 2.0 mm and <= 4.5 mm.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code QCA (Intracranial coil-assist stent).
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for MicroVention, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K254035 · Decided Sep 3, 2026 · 261 days after receipt
Device type: Aspiration Thrombectomy Catheter (QEZ) · Cardiology
K261808 · Decided Jun 30, 2026 · 29 days after receipt
Device type: Catheter, Percutaneous, Neurovasculature (QJP) · Cardiology
K261549 · Decided Jun 9, 2026 · 29 days after receipt
Device type: Catheter, Percutaneous, Neurovasculature (QJP) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.